Bottom line
What is HRLRX's expense ratio?
HRLRX's expense ratio is 1.5%, or about $150 a year on every $10,000 invested. That is more expensive than 84% of large blend funds we track (median 0.83%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Feb 26, 2026
HRLRX fee table
| Net expense ratio | 1.5% |
|---|---|
| Gross expense ratio | 2.01% |
| Management fee | 0.8% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.71% |
| Fee waiver / reimbursement | -0.51% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What HRLRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| HRLRX | $153 | $581 | $1,036 | $2,297 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.5% expense ratio costs roughly $79,500 in lost growth, versus about $46,700 for the median large blend fund (0.83%).